Financial results - BALANCE PHARMA S.R.L.

Financial Summary - Balance Pharma S.r.l.
Unique identification code: 45812008
Registration number: J2022005056400
Nace: 4646
Sales - Ron
7.001
Net Profit - Ron
-10.233
Employees
1
Open Account
Company Balance Pharma S.r.l. with Fiscal Code 45812008 recorded a turnover of 2024 of 7.001, with a net profit of -10.233 and having an average number of employees of 1. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Balance Pharma S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 150.250 166.590 7.001
Total Income - EUR - - - - - - - 150.345 166.598 7.001
Total Expenses - EUR - - - - - - - 144.580 59.669 17.235
Gross Profit/Loss - EUR - - - - - - - 5.766 106.928 -10.233
Net Profit/Loss - EUR - - - - - - - 4.293 105.462 -10.233
Employees - - - - - - - 0 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales decreased by -95.8%, from 166.590 euro in the year 2023, to 7.001 euro in 2024. The Net Profit decreased by -104.873 euro, from 105.462 euro in 2023, to 0 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Balance Pharma S.r.l.

Rating financiar

Financial Rating -
BALANCE PHARMA S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Balance Pharma S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Balance Pharma S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Balance Pharma S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Balance Pharma S.r.l. - CUI 45812008

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 0 0 0
Current Assets - - - - - - - 199.686 281.996 106.319
Inventories - - - - - - - 16.244 4.510 12.787
Receivables - - - - - - - 181.661 275.625 93.289
Cash - - - - - - - 1.781 1.861 243
Shareholders Funds - - - - - - - 4.334 109.783 98.936
Social Capital - - - - - - - 0 40 40
Debts - - - - - - - 195.353 172.213 7.383
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 106.319 euro in 2024 which includes Inventories of 12.787 euro, Receivables of 93.289 euro and cash availability of 243 euro.
The company's Equity was valued at 98.936 euro, while total Liabilities amounted to 7.383 euro. Equity decreased by -10.234 euro, from 109.783 euro in 2023, to 98.936 in 2024.

Risk Reports Prices

Reviews - Balance Pharma S.r.l.

Comments - Balance Pharma S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.